Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract

Transplant Infectious Disease

Volumn 11, Issue 5, 2009, Pages 467-470

  Pogue, J M ^a   Depestel, D D ^b,c   Kaul, D R ^d   Khaled, Y ^c   Frame, D G ^b,c  

^a SINAI GRACE HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CDAD; Clostridium difficile; Graft versus host disease; GVHD; Peripheral blood stem cell transplant; Vancomycin

Indexed keywords

BUDESONIDE; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; RAPAMYCIN; RIFAXIMIN; VANCOMYCIN;

ADULT; ARTICLE; BACTEREMIA; BRAIN DISEASE; CANDIDA GLABRATA; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS; DEATH; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN HERPESVIRUS 6; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SIDE EFFECT; VANCOMYCIN RESISTANT ENTEROCOCCUS; VIRUS REACTIVATION;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; VANCOMYCIN;

EID: 70349666859     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00426.x     Document Type: Article

References (13)

1. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007 45 : 302 307.
2. Product information. Vancocin (vancomycin hydrochloride capsules, USP pulvules). Indianapolis, IN : Eli Lilly and Company, 2000.
3. Spitzer PG, Eliopoulos GM. Systemic absorption of enteral vancomycin in a patient with pseudomembranous colitis. Ann Intern Med 1984 100 (4) : 533 534.
4. Matzke GR, Halstenson CE, Olson PL, Collins AJ, Abraham PA. Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitis. Am J Kidney Dis 1987 5 : 422 425.
5. Armstrong CJ, Wilson TS. Systemic absorption of vancomycin. J Clin Pathol 1995 48 : 689.
6. Tedesco F, Markham R, Gurwith M, Christie D, Bartlett JG. Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet 1978 2 : 226 228. (Pubitemid 8400351)
7. Dudley MN, Quintiliani R, Nightingale, Gontarz N. Absorption of vancomycin. Ann Intern Med 1984 101 : 144.
8. Aradhyula S, Manian FA, Hafidh SA, Bhutto SS, Alpert MA. Significant absorption of oral vancomycin in a patient with Clostridium difficile colitis and normal renal function. South Med J 2005 99 (5) : 518 520.
9. Fekely R, Silva J, Kauffman, Buggy B, Deery HG. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 1989 86 (1) : 15 19.
10. Osawa R, Kaka A. Maculopapular rash induced by oral vancomycin. Clin Infect Dis 2008 47 : 880 881.
11. Bailey P, Gray H. An elderly woman with "Red Man Syndrome" in association with oral vancomycin therapy: a case report. Cases J 2008 1 : 111.
12. Leisenring WM, Martin PJ, Petersdorf EW, et al. An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. Blood 2006 108 (2) : 749 755.
13. Kelly C, LaMont JT. Clostridium difficile - more difficult than ever. N Engl J Med 2008 359 : 1932 1940.